(Q45752195)

English

Transient selection of a hepatitis B virus polymerase gene mutant associated with a decreased replication capacity and famciclovir resistance

scientific article published in January 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9862871

Transient selection of a hepatitis B virus polymerase gene mutant associated with a decreased replication capacity and famciclovir resistance (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9862871

Hepatitis B virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

C Pichoud

1

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9862871

B Seignères

2

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9862871

Z Wang

3

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9862871

C Trépo

4

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9862871

F Zoulim

5

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9862871

language of work or name

0 references

publication date

1 January 1999

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9862871

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9862871

29

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9862871

1

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9862871

230-237

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9862871

Drug therapy for chronic hepatitis B: antiviral efficacy and influence of hepatitis B virus polymerase mutations on the outcome of therapy.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290119

21 January 2018

The treatment of chronic viral hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290119

21 January 2018

Viral dynamics in hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290119

21 January 2018

Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290119

21 January 2018

A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290119

21 January 2018

A novel vector for the study of hepatitis delta virus replication

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290119

21 January 2018

Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290119

21 January 2018

Hepatitis B virus surface antigen and polymerase gene variants: potential virological and clinical significance

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290119

21 January 2018

Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290119

21 January 2018

The guanine nucleoside analog penciclovir is active against chronic duck hepatitis B virus infection in vivo.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290119

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro antiviral activity of penciclovir, a novel purine nucleoside, against duck hepatitis B virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290119

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of hepatitis B virus DNA polymerase by enantiomers of penciclovir triphosphate and metabolic basis for selective inhibition of HBV replication by penciclovir

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290119

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibitory Effect of Penciclovir-Triphosphate on Duck Hepatitis B Virus Reverse Transcription

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290119

7 January 2021

based on heuristic

inferred from DOI database lookup

A double blind, placebo-controlled study to assess the effect of famciclovir on virus replication in patients with chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290119

7 January 2021

based on heuristic

inferred from DOI database lookup

A preliminary trial of lamivudine for chronic hepatitis B infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290119

7 January 2021

based on heuristic

inferred from DOI database lookup

Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers: a placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290119

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanisms of nucleoside analog antiviral activity and resistance during human immunodeficiency virus reverse transcription

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290119

7 January 2021

based on heuristic

inferred from DOI database lookup

Origin and evolution of retroelements based upon their reverse transcriptase sequences

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290119

7 January 2021

based on heuristic

inferred from DOI database lookup

Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290119

7 January 2021

based on heuristic

inferred from DOI database lookup

Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290119

7 January 2021

based on heuristic

inferred from DOI database lookup

Lamivudine resistance inimmunocompetent chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290119

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis B virus polymerase mutations during antiviral therapy in a patient following liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290119

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of infectious woodchuck hepatitis virus in murine and avian fibroblasts

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290119

7 January 2021

based on heuristic

inferred from DOI database lookup

A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290119

7 January 2021

based on heuristic

inferred from DOI database lookup

Mutational analysis of the hepatitis B virus P gene product: domain structure and RNase H activity

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290119

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics of famciclovir in subjects with chronic hepatic disease.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290119

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification of BMS-200475 as a potent and selective inhibitor of hepatitis B virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290119

7 January 2021

based on heuristic

inferred from DOI database lookup

Penciclovir is a selective inhibitor of hepatitis B virus replication in cultured human hepatoblastoma cells

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290119

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEP.510290119

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9862871

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9862871

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45752195&oldid=2080984748"